← Eichor
Condition: Ulcerative Colitis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Ulcerative Colitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC)
NA · 1 location(s) · University of Miami · NCT06784323Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.
Phase 2 · 1 location(s) · Tanta University · NCT05575505Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-medi
Phase N/A · 4 location(s) · Meyer Children's Hospital IRCCS · NCT06862843Confirmatory Clinical Study in Active Ulcerative Colitis
Phase 2 · 16 location(s) · MRM Health NV · NCT07296315Top Down Versus Step up in Pediatric Ulcerative Colitis
Phase 4 · 1 location(s) · Children's Hospital of Fudan University · NCT04999228Digestive Biobank for Exploring Microbiota-host Interactions
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05704413The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC
Phase 2 · 1 location(s) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · NCT07507513Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
Phase N/A · 12 location(s) · TIDHI Innovation Inc. · NCT07245394Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease
Phase N/A · 1 location(s) · Shmuel Kivity, MD · NCT07644117A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
Phase N/A · 38 location(s) · Pfizer · NCT06294925Evaluation of the SMART IBD App in Pediatric IBD
NA · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07195123Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis
NA · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06095596Clinical Investigation of MYIBDDiet App Developed for Inflammatory Bowel Disease (IBD) Patients to Self-manage Their Die
NA · 1 location(s) · University of Alberta · NCT06683105PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease
NA · 1 location(s) · Pontificia Universidad Catolica de Chile · NCT06758024A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants
Phase 1 · 1 location(s) · Jiangsu Carephar Pharmaceutical Co., Ltd. · NCT06627556The PODIUM Study - a Three-arm Comparison of Target Therapies After Anti-TNFα in Ulcerative Colitis
Phase N/A · 1 location(s) · Humanitas Clinical and Research Center · NCT06691061An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cy
Phase 1 · 7 location(s) · Hoffmann-La Roche · NCT07665723Personalized B-fructan Diet in Inflammatory Bowel Disease Patients
NA · 2 location(s) · University of Manitoba · NCT05615779Combination of Diet and Oral Budesonide for Ulcerative Colitis
NA · 6 location(s) · Wolfson Medical Center · NCT05791487TIDHI Mental Health in IBD Patients Study
NA · 1 location(s) · TIDHI Innovation Inc. · NCT07013578R-3750 in Patients With Mild to Moderate Ulcerative Colitis
Phase 1 · 5 location(s) · Rise Therapeutics LLC · NCT05666960Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
Phase N/A · 1 location(s) · Massachusetts General Hospital · NCT06655415Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease
Phase N/A · 6 location(s) · Mercy Medical Center · NCT06750731An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintena
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT03167437Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis
Phase N/A · 1 location(s) · Qilu Hospital of Shandong University · NCT07111572A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Phase 2 · 67 location(s) · Sanofi · NCT06975722LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Phase 2 · 147 location(s) · Eli Lilly and Company · NCT07186101Efficacy of Probiotics in Patients With IBD
NA · 1 location(s) · The First Affiliated Hospital of Xinxiang Medical College · NCT05652621A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease an
Phase N/A · 4 location(s) · AbbVie · NCT07421258A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Phase 2 · 45 location(s) · Pfizer · NCT05287126
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.